Evidence map›Paper›PMID 38640244›Full record

ArticleScience advances2024

Tissue-specific genetic variation suggests distinct molecular pathways between body shape phenotypes and colorectal cancer.

Laia Peruchet-Noray, Anja M Sedlmeier, Niki Dimou, Hansjörg Baurecht, Béatrice Fervers, Emma Fontvieille, Julian Konzok, Kostas K Tsilidis, Sofia Christakoudi, Anna Jansana and 20 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 18 institutions in 7 countries.

Laia Peruchet-NorayInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0001-8742-8920
Anja M SedlmeierCenter for Translational Oncology, University Hospital Regensburg, Regensburg, Germany.ORCID 0000-0002-7564-3065
Niki DimouInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0003-1678-9328
Hansjörg BaurechtDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-9265-5594
Béatrice FerversDépartement Prévention Cancer Environnement, Centre Léon Bérard, Lyon, France.ORCID 0000-0003-3498-6499
Emma FontvieilleInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.
Julian KonzokDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-4232-4105
Kostas K TsilidisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.ORCID 0000-0002-8452-8472
Sofia ChristakoudiDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Anna JansanaInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0001-8504-1618
Reynalda CordovaInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0002-7781-6433
Patricia BohmannDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-0931-8651
Michael J SteinDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-1120-1751
Andrea WeberDepartment of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.ORCID 0000-0002-4777-7808
Stéphane BézieauService de Génétique Médicale, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France.ORCID 0000-0003-0095-1319
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Andrew T ChanClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-7284-6767
Iona ChengDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Jane C FigueiredoDepartment of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Koldo Garcia-EtxebarriaBiodonostia, Gastrointestinal Genetics Group, San Sebastián, Spain.ORCID 0000-0002-6107-9416
Victor MorenoDepartment of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.ORCID 0000-0002-2818-5487
Christina C NewtonDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.ORCID 0000-0003-1471-5608
Stephanie L SchmitGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0001-5931-1194
Mingyang SongClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1324-0316
Cornelia M UlrichHuntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-7641-059X
Pietro FerrariInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0001-9358-7338
Vivian ViallonInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0002-9799-4421
Robert Carreras-TorresDigestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), Salt, Girona, Spain.ORCID 0000-0002-2925-734X
Marc J GunterInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0001-5472-6761
Heinz FreislingInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 69366 Lyon CEDEX 07, France.ORCID 0000-0001-8648-4998
Centre international de recherche sur le cancer · FRUniversity of Regensburg · DEHarvard University · USAmerican Cancer Society · USBiogipuzkoa Health Research Institute · ESCedars-Sinai Medical Center · USCentre Hospitalier Universitaire de Nantes · FRCentre Léon Bérard · FRCleveland Clinic · USGerman Cancer Research Center · DEInstitut d'Investigació Biomédica de Bellvitge · ESInstitut d'Investigació Biomèdica de Girona · ESKing's College London · GBUniversity Hospital Regensburg · DEUniversity of California, San Francisco · USUniversity of Ioannina · GRUniversity of Utah · USUniversity of Vienna · AT

Funding

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
Ceramides as novel drivers of metabolic dysfunction and colorectal cancerU01CA272529 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Mary Christine Playdon, SCOTT A SUMMERS · 2022 to 2026
$4.7M
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer linkR01CA254108 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HURSTING, STEPHEN D, ULRICH, CORNELIA M · 2021 to 2025
$3.2M
NCI NIH HHS R01 CA254108NCI NIH HHS U01 CA167551NCI NIH HHS U01 CA206110NCI NIH HHS U01 CA272529World Health Organization 001
6 · The paper itself

Abstract

It remains unknown whether adiposity subtypes are differentially associated with colorectal cancer (CRC). To move beyond single-trait anthropometric indicators, we derived four multi-trait body shape phenotypes reflecting adiposity subtypes from principal components analysis on body mass index, height, weight, waist-to-hip ratio, and waist and hip circumference. A generally obese (PC1) and a tall, centrally obese (PC3) body shape were both positively associated with CRC risk in observational analyses in 329,828 UK Biobank participants (3728 cases). In genome-wide association studies in 460,198 UK Biobank participants, we identified 3414 genetic variants across four body shapes and Mendelian randomization analyses confirmed positive associations of PC1 and PC3 with CRC risk (52,775 cases/45,940 controls from GECCO/CORECT/CCFR). Brain tissue-specific genetic instruments, mapped to PC1 through enrichment analysis, were responsible for the relationship between PC1 and CRC, while the relationship between PC3 and CRC was predominantly driven by adipose tissue-specific genetic instruments. This study suggests distinct putative causal pathways between adiposity subtypes and CRC.

Indexed as

Colorectal NeoplasmsSomatotypesGenetic VariationGenome-Wide Association StudyHumansObesityPhenotypeRisk Factors

Identifiers

PMID38640244
PMCPMC11029802
OpenAlexW4394950979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.